Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Download a publication order form here or subscribe here.
MDL Mass Tort & Class Action Monitor - Issue: 32
JPML Puts Allergan Biocell Textured Breast Implant MDL Petition on Dec. Hearing Docket
FDA Draft Guidance Recommends Boxed Warning for Breast Implants
Colo. Man Sues Zantac Makers, Says Heartburn Drug Caused Bladder Cancer
4 States Reach $48 Billion Settlement in Principle with Opioid Makers, Distributors
Sanofi Recalls Zantac Amid Concerns of NDMA Contamination
Massachusetts’ Temporary Ban on Vaping Products Sales to Remain in Place
Teva, Distributors Reach Settlement with Ohio Counties on Eve of Opioid Trial
N.M. Federal Judge Splits Gold King Mine MDL Trial Into 3 Phases
